News
-
Data show oral nalbuphine significantly reduces chronic cough in idiopathic pulmonary fibrosis
Experts discuss the promising results—particularly surrounding patient-reported outcomes in this population—and the need for long-term safety data.
-
Large, longitudinal study adds to evidence that links OSA to mental health disorder
Colin Huntley, MD, said the data help to confirm what many have seen in the clinic and suggest that patients may see mental health improvements if their sleep apnea is better managed.
-
Study finds triple combination modulator therapy reduces inflammation in CF
Valentino Bezzerri, PhD, discusses findings from a compassionate-use study examining the effects of elexacaftor/tezacaftor/ivacaftor on inflammation in patients with cystic fibrosis.
-
Real-world data show adherence to nodal dissection standard improves detection of lymph node involvement in patients with NSCLC
Increased lymph node analysis was associated with a 2.1% absolute increase in pathologic nodal upstaging, according to recent research.
-
Study links nocturnal GERD, undiagnosed OSA to worse outcomes in IPF
Researchers said the findings support evaluation of sleep‑related comorbidities to identify potentially modifiable contributors to symptoms and physiologic impairment.
-
Effects of LAMA or ICS withdrawal may increase risk for COPD exacerbations
Discontinuing LAMA or ICS treatment may more than double the risk of exacerbations for up to 90 days, according to an analysis by Alexander Mathioudakis, MD, PhD.
-
RSV hospitalization increases cardiorespiratory event, COPD exacerbation risk
Caihua Liang, MD, PhD, and Elizabeth Begier, MD, discuss the importance of prevention in light of data showing elevated risk for up to 180 days following the acute infection.
-
Bilateral lung transplant comparable to heart-lung transplant in primary PAH
Recent findings reinforce the widely used strategy of bilateral lung transplantation for most patients with primary PAH who do not have structural heart disease.
-
Intranasal saline improves symptoms in children with sleep-disordered breathing
The results of the MIST+ trial support the conclusion that saline is as effective as corticosteroid in managing symptoms of OSDB, said lead author Gillian Nixon, MD.
-
Inside the 2025 CPR and ECC guideline updates from the AHA
Ashish Panchal, MD, PhD, and Daniel Arellano, PhD, RN, APRN, ACNP-BC, review new guidelines that prioritize improved survival rates and neurological outcomes.
